Tensilon

Active Ingredient(s): Edrophonium
FDA Approved: * May 3, 1951
Pharm Company: * VALEANT PHARM INTL
Category: Myasthenic Syndrome

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tensilon Overview

Edrophonium is a readily reversible acetylcholinesterase inhibitor. It prevents breakdown of the neurotransmitter acetylcholine and acts by competitively inhibiting the enzyme acetylcholinesterase, mainly at the neuromuscular junction. It is sold under the trade names Tensilon and Enlon (according to FDA Orange Book). Contents 1 Clinical uses 2 Chemistry 3 Pharmacokinetics 4 Sources 5 References Clinical uses Edrophonium (by the so-called Tensilon test) is used to differentiate myast...

Read more Tensilon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Edrophonium

Recent Tensilon Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Edrophonium
  • Injection: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Edrophonium or a similar ingredient: (5 results)

Related Tensilon Topics:

tensilon pharmacies
We're looking for Tensilon for a patient in India under medical prescription. Pl contact asap. ## this is an informa... 1 reply






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA